Pregnancy outcome following exposure to orlistat, ramipril, glimepiride in a woman with metabolic syndrome

Authors

• Nuri I. Kalyoncu, Department of Pharmacology, Karadeniz Technical University, School of Medicine, Trabzon, Turkey
• Fusun Yaris, Department of Family Medicine, Ondokuzmayis University, School of Medicine, Trabzon, Turkey.
• Mine Kadioglu, Department of Pharmacology, Karadeniz Technical University, School of Medicine, Trabzon, Turkey
• Murat Kesim, Assistant Professor, Department of Pharmacology, Karadeniz Technical University, School of Medicine, TR-61187, Trabzon, Turkey. E-mail: mkesim{at}meds.ktu.edu.tr
• Cunay Ulku, Department of Pharmacology, Karadeniz Technical University, School of Medicine, Trabzon, Turkey.
• Ersin Yaris, Department of Pharmacology, Karadeniz Technical University, School of Medicine, Trabzon, Turkey.
• Mesut Unsal, Department of Obstetrics and Gynecology, Karadeniz Technical University, School of Medicine, Trabzon, Turkey.
• Mustafa Dikici, Department of Family Medicine, Ondokuzmayis University, School of Medicine, Trabzon, Turkey

Article Type

Brief Report

First Page

497

Last Page

499

Recommended Citation

Kalyoncu, Nuri I.; Yaris, Fusun; Kadioglu, Mine; Kesim, Murat; Ulku, Cunay; Yaris, Ersin; Unsal, Mesut; and Dikici, Mustafa (2005) "Pregnancy outcome following exposure to orlistat, ramipril, glimepiride in a woman with metabolic syndrome," Saudi Medical Journal: Vol. 26: Iss. 3, Article 35.
DOI: https://doi.org/10.15537/1658-3175.2897